Kara-Lee Aves

Kara-Lee Aves is a Senior Research Consultant in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. She is affiliated with NIVI Research and VLPVAC, focusing on advanced vaccine platform development using virus-like particles.

Her research interests span vaccine development, immunology, and structural vaccinology with particular expertise in malaria, influenza, and veterinary vaccines. Dr. Aves has made significant contributions to the field of virus-like particle (VLP) technology, developing novel platforms for antigen presentation and vaccine stabilization.

Her publication record shows substantial impact, with her 2021 Nature Communications paper on SARS-CoV-2 VLPs receiving over 100 citations. Her recent work demonstrates continued innovation in mRNA vaccine platforms, thermostable formulations, and veterinary applications. Her research bridges basic immunological principles with practical vaccine solutions for both human and animal health.

Dr. Aves collaborates extensively with researchers across multiple institutions, particularly with Sander A.F., Nielsen M.A., and other prominent scientists in the vaccine field. Her work has received attention from news outlets, social media, and scientific communities, with several publications being featured in major media outlets.